ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
31.115
-0.01
(-0.03%)
마감 02 2월 6:00AM
실시간 데이터

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
31.115
매수가
31.08
매도가
31.15
거래량
15,821
31.145 일간 변동폭 31.415
19.392 52주 범위 31.415
market_cap
전일 종가
31.125
개장가
31.20
최근 거래 시간
100
@
31.165
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
14,099
발행 주식
802,979,942
배당수익률
2.89%
주가수익률
10.07
주당순이익(EPS)
3.1
매출
41.26B
순이익
2.49B

Societe Generale SA 정보

섹터
Finance Services
산업
Finance Services
본부
Paris, Fra
설립됨
-
Societe Generale SA is listed in the Finance Services sector of the Tradegate (DE) with ticker SGE. The last closing price for Societe Generale was 31.13 €. Over the last year, Societe Generale shares have traded in a share price range of 19.392 € to 31.415 €.

Societe Generale currently has 802,979,942 shares in issue. The market capitalisation of Societe Generale is 24.99 € billion. Societe Generale has a price to earnings ratio (PE ratio) of 10.07.

SGE 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.13.6648342495430.01531.41529.721472430.71837562DE
43.81513.974358974427.331.41526.481871228.88393994DE
124.38516.40478862726.7331.41524.0051409927.45815699DE
266.9928.974093264224.12531.41519.3921644224.46995434DE
527.2930.598111227723.82531.41519.3921544124.29198073DE
156-1.785-5.4255319148932.937.64518.351230123.87566175DE
2601.444.8525695029529.67537.64510.8361262021.55423417DE

SGE - Frequently Asked Questions (FAQ)

What is the current Societe Generale share price?
The current share price of Societe Generale is 31.115 €
How many Societe Generale shares are in issue?
Societe Generale has 802,979,942 shares in issue
What is the market cap of Societe Generale?
The market capitalisation of Societe Generale is EUR 24.99B
What is the 1 year trading range for Societe Generale share price?
Societe Generale has traded in the range of 19.392 € to 31.415 € during the past year
What is the PE ratio of Societe Generale?
The price to earnings ratio of Societe Generale is 10.07
What is the cash to sales ratio of Societe Generale?
The cash to sales ratio of Societe Generale is 0.61
What is the reporting currency for Societe Generale?
Societe Generale reports financial results in EUR
What is the latest annual turnover for Societe Generale?
The latest annual turnover of Societe Generale is EUR 41.26B
What is the latest annual profit for Societe Generale?
The latest annual profit of Societe Generale is EUR 2.49B
What is the registered address of Societe Generale?
The registered address for Societe Generale is 29 BOULEVARD HAUSSMANN, PARIS, 75009
What is the Societe Generale website address?
The website address for Societe Generale is www.societegenerale.com
Which industry sector does Societe Generale operate in?
Societe Generale operates in the FINANCE SERVICES sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
0T8BTCTM Kids IT Education Inc
0.845 €
(380.11%)
187.08k
3XUHuijing Holdings Co Ltd
0.003 €
(50.00%)
5.17k
E3O1Nexoptic Technology Corp
0.0225 €
(50.00%)
1.34k
9I0Pluto Ventures Inc
0.35 €
(49.57%)
17.2k
VOPInvestigator Resources Ltd
0.0195 €
(44.44%)
3.08k
WWTWater Ways Technologies Inc
0.002 €
(-50.00%)
48.77k
AWY0Percheron Therapeutics Ltd
0.003 €
(-45.45%)
1,000
45AAlchemy Resource Ltd
0.0025 €
(-37.50%)
95.16k
41KQuebec Rare Earth Elements Corp
0.021 €
(-34.38%)
63k
POTAPortofino Resources Inc
0.0038 €
(-32.14%)
15k
D7GNel ASA
0.2011 €
(0.05%)
3.39M
DMLSayona Mining Limited
0.015 €
(7.14%)
1.95M
3CPXiaomi Corporation
4.90 €
(-3.92%)
1.78M
RQ0DWave Quantum Inc
5.742 €
(5.82%)
1.35M
HPMHorizon Petroleum Ltd
0.15 €
(11.11%)
1.01M
surfkast surfkast 4 분 전
great DD! I am sure you just got 1000 more investors interested.
WNFT
Boing x 2 Boing x 2 6 분 전
New PR, Just increased Spacex shares to 11Percent 108,000 shares,

"https://www.prnewswire.com/news-releases/xovr-etf-expands-spacex-investment-with-additional-13m-raising-position-to-11-of-aum-302365606.html"

They should be able to get to 15Percent their limit.
XOVR
trunkmonk trunkmonk 7 분 전
I’m sure u and u follower agree on this.
FNMA
Kam8 Kam8 3 시간 전
LP just doesn't accept Settlement and go discovery🤞😆🤞, I don't think MMs want discovery so they might accept big money for settlement. 😆😆
NWBO
manibiotech manibiotech 3 시간 전
Agree
Usual few will pump this anyway 
NWBO
manibiotech manibiotech 3 시간 전
lol 
The ceiling has already been put at 40M shares
So dream on
NWBO
Deportes Deportes 3 시간 전
Gfy is that better?
ENZC
Hicham007 Hicham007 3 시간 전
Painful but nothing new...

I have averaged down my portfolio to 6.6$ down from 9.8 and I have now 140k shares and i am ready to increase it to 200k if the SP continues on  dropping.  By now Iova is my only stock market investment so we can say all In...

I am ready finan
IOVA
jammy32 jammy32 3 시간 전
As soon as Trump the genius mentioned Tariffs on pharmaceuticals, this puppy got sick and dropped seven cents. Not good. Shouldn’t Nasrat tell us what this means for Elite. Are we subject to the tariffs where is the API from. Is this a good thing or bad thing. Does nasrat know. Does he
API
rosemountbomber rosemountbomber 3 시간 전
Sleven am I understanding correctly that the Generics get their API from China and Amarin doesn't?
API
BlazingStocks BlazingStocks 4 시간 전
$ILLR Triller CEO Sean Kim joins Yahoo Finance to discuss the fight for TikTok's market share and the outlook for the creator economy:https://x.com/YahooFinance/status/1885453406485033258?t=ldZluPpc4DCzgBoH3GagOA&s=19
ILLR
barnstormer barnstormer 4 시간 전
OK Zadie, the judge only allowed a lousy 40 million shares. Still, consider the following (quick back of the envelope math)

40,000,000 shares / (2752(avg daily volume) x 252 (avg yearly trading days) = 700,104 avg yearly shares traded
40,000,000 shares / 700,104 = 57.14 years
NWBO
BlazingStocks BlazingStocks 4 시간 전
Thank you for sharing this! 
ILLR
VMLG17 VMLG17 4 시간 전
And they’d be stupid if they didn’t settle. If a jury learns that the MMs have continued spoofing after the lawsuit was filed, then damages could be more than any settlement amount, not to mention criminal charges later.
NWBO
Macod Macod 4 시간 전
CHANGE in outstanding shares. First change in over a year. Should be more shares reflected with next update. Those lucky enough to buy privates be on the lookout for your certs

O/S 526,142,269
Restricted 297,633,160
Unrestricted 228,509,109

Increase of 7,6
MRGE
mascale mascale 4 시간 전
Hiru Prepared: Likely for new JORC, 2025, Canadian standard less likely needed. ERM is noted in Hiru basis reporting. "Resource reporting and compliance: we prepare mineral resource reports in accordance with international reporting standards such as NI 43-101, JORC, and CIM. Our experts ensure t
HIRU
stealofadeal stealofadeal 4 시간 전
$ BLTHD The way this is looking with not much on the offer we are going much higher. We are sitting way under the radar. I saw 12.00 the third market maker down on the ask.
BLTHD
nowwhat2 nowwhat2 4 시간 전
scoop um up right at black swan.
XRPUSD
loophole lawyer loophole lawyer 4 시간 전
The 3 most important letters for GTCH…..P,C,T……Checkmate
GTCH
Preciouslife1 Preciouslife1 4 시간 전
https://www.mlb.com/news/mets-counting-on-trade-deadline-additions
jxyzobrien jxyzobrien 4 시간 전
hope you are well
sounds like your company is doing great
say hi when you can
flipper44 flipper44 4 시간 전
The court’s R&R did conclude and preserve NWBO illegal spoofing claims alleged to have been committed by defendants.
NWBO
x993231 x993231 4 시간 전
He does like to make a mountain out of a mole hill, but that is what he gets paid to do.  I have him and many of his alternate ID's on ignore.  He is good at asking, why, why, why.  

X. Yves is good at doing his thing.  Funny remember when Lebby said if I don't perform by the end of t
LWLG
havnagoodtime havnagoodtime 4 시간 전
So, what is the short interest and the FTD report on DPLS? Thanks in advance.
DPLS
MartinLutherKing MartinLutherKing 4 시간 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ